Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
Daniel Peisert
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
specialty pharmaceuticals
|
| gptkbp:formerName |
gptkb:Depomed,_Inc.
|
| gptkbp:founded |
1995
|
| gptkbp:headquartersLocation |
gptkb:Lake_Forest,_Illinois,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Nucynta
gptkb:Cambia gptkb:Zipsor gptkb:Gralise |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:tradedOn |
NASDAQ: ASRT
|
| gptkbp:website |
https://www.assertiotx.com/
|
| gptkbp:bfsParent |
gptkb:Spectrum_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Assertio Holdings
|